Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies.
about
Universal vaccines: shifting to one for manyInhibition of fungal beta-1,3-glucan synthase and cell growth by HM-1 killer toxin single-chain anti-idiotypic antibodies.Serologic response to cell wall mannoproteins and proteins of Candida albicansAnalysis of vaginal cell populations during experimental vaginal candidiasis.Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicansProduction of an engineered killer peptide in Nicotiana benthamiana by using a potato virus X expression system.Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.Candida-specific antibodies during experimental vaginal candidiasis in mice.Vaccines against CoccidioidesImmunopathogenesis of recurrent vulvovaginal candidiasis.Yeast killer systemsGrowth inhibition of Candida species by Wickerhamomyces anomalus mycocin and a lactone compound of Aureobasidium pullulansProspects for development of a vaccine to prevent and control vaginal candidiasis.Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity.Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasisRats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection.Antibody immunity and invasive fungal infectionsProtective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats.A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities.Antibody Peptide based antifungal immunotherapyAnticandidal immunity and vaginitis: novel opportunities for immune intervention.New approaches in the development of a vaccine for mucosal candidiasis: progress and challengesTherapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis.A novel glyco-conjugate vaccine against fungal pathogens.Inhibitory effect of human natural yeast killer toxin-like candidacidal antibodies on Pneumocystis cariniiIdentification of continuous B-cell epitopes on the protein moiety of the 58-kiloDalton cell wall mannoprotein of Candida albicans belonging to a family of immunodominant fungal antigens.Monoclonal yeast killer toxin-like candidacidal anti-idiotypic antibodies.
P2860
Q30392373-36DE7B8B-6A54-4E30-AD5B-ED623000A13DQ33255739-17CE5EF7-34E3-4FA2-93A6-3DC498BD8477Q33992594-9FA91AD6-0439-4781-B9C6-7D4B9B4763EEQ34001275-D5FE5AE1-D6FD-419B-83AB-0B28546E7EDCQ34004652-926856F7-C223-4CDE-BB82-AFACDB80461FQ34097853-0050DDF3-15D4-4D18-A937-C7CE42E26911Q34131697-1154E534-6124-410A-990D-6C3E19D6B7ECQ34131799-5580FBE9-5997-46A5-95B2-13EB40EB05CDQ34358234-D1E334C2-34AC-49FF-800B-675B56AB0DEFQ34397458-3EC650E4-C596-42B7-AC0C-1616D7A5A9D5Q34433041-6943E264-D412-420A-8480-447AA74F7821Q34582430-BC33F7E5-A17C-4C34-B3AD-D9B7E54D5639Q34707478-70E2EC06-1430-4238-B890-2213E45F9E9DQ35385497-D8644ADF-3D89-4106-8B2D-AFF8FFD8D2ACQ35420588-F0E09CE7-FF1C-4D7E-8478-F189B378DF4EQ35423051-78FC1C59-D411-4694-96AF-0851F2D6E9A9Q35447692-9DC467BE-7354-4460-B8BE-322A27169B9DQ35553521-92069C76-5B3C-45A4-B4D6-4B5D064EFFA9Q35802339-1148D7B6-3D29-4F47-AA7C-11121DA422D5Q36003400-30FB0516-FA40-4E4C-A760-3171AD34CC8AQ36097307-5E21D329-00E3-47F4-8E0B-3CF096F17FC7Q36158337-FA2B19AF-54D9-49F8-8862-B23A6F27E9BCQ36376056-D6F65A29-EC90-4784-88C1-39053231026DQ36402820-42A06129-BBA1-423E-8F8B-45E98D693B88Q36437959-257F0960-051D-4401-9B8E-969A68E641D8Q39519765-EE4AECF6-55F9-43B2-B9B1-60EA47B3792FQ39811118-892DFABF-2A17-497B-9983-0D229779030F
P2860
Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies.
description
1994 nî lūn-bûn
@nan
1994 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մարտին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Idiotypic intravaginal vaccina ...... ike anti-idiotypic antibodies.
@ast
Idiotypic intravaginal vaccina ...... ike anti-idiotypic antibodies.
@en
Idiotypic intravaginal vaccina ...... ike anti-idiotypic antibodies.
@nl
type
label
Idiotypic intravaginal vaccina ...... ike anti-idiotypic antibodies.
@ast
Idiotypic intravaginal vaccina ...... ike anti-idiotypic antibodies.
@en
Idiotypic intravaginal vaccina ...... ike anti-idiotypic antibodies.
@nl
prefLabel
Idiotypic intravaginal vaccina ...... ike anti-idiotypic antibodies.
@ast
Idiotypic intravaginal vaccina ...... ike anti-idiotypic antibodies.
@en
Idiotypic intravaginal vaccina ...... ike anti-idiotypic antibodies.
@nl
P2093
P1476
Idiotypic intravaginal vaccina ...... ike anti-idiotypic antibodies.
@en
P2093
Boccanera M
De Bernardis F
Magliani W
Polonelli L
P304
P407
P577
1994-03-01T00:00:00Z